INTELLEXON GMBH has a total of 19 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are ORIGENE TECHNOLOGIES INC, DAKO AS and NAT BIO FOUNDER BIOTECHNOLOGY CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | Canada | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | United States | 2 | |
#5 | Australia | 1 | |
#6 | Israel | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Pharmaceuticals | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Peptides | |
#3 | Measuring microorganism processes | |
#4 | Medical preparations | |
#5 | Therapeutic chemical compounds | |
#6 | Combinatorial chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Würfel Wolfgang | 14 |
#2 | Winterhalter Christoph | 10 |
#3 | Wirtz Ralph Markus | 9 |
#4 | Würfel Franziska | 7 |
#5 | Wurfel Wolfgang | 4 |
#6 | Wurfel Franziska | 2 |
#7 | Wirtz Ralph M | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021078680A1 | Hla class i molecules in in vitro fertilization and further medical implications | |
WO2021078679A1 | Hla-h, hla-j, hla-l, hla-v and hla-y as therapeutic and diagnostic targets | |
WO2021005001A1 | Hla-h in medicine and diagnostics | |
WO2021005002A1 | Methods for diagnosing the effectiveness of anti-tumor treatment | |
WO2021004934A1 | Determining individual hla patterns, use as prognosticators, target genes and therapeutic agents | |
KR20210005186A | HLA-J and its medical/diagnostic uses |